Amgen (NASDAQ:AMGN) will present at the 2025 J.P. Morgan Healthcare Conference at 3:00 p.m. PT on Monday 13, 2025. Robert A.

Amgen Inc. closed $84.79 short of its 52-week high ($346.85), which the company achieved on July 25th.

Shares of Amgen Inc. AMGN slipped 1.01% to $258.59 Monday, on what proved to be an all-around mixed trading session for the ...

Amgen has a strong product portfolio, pipeline developments, and robust financial health. Read why AMGN stock is a Strong Buy ...

Article analyzes Amgen's strong clinical progress and financials, recommending caution due to valuation and technical ...

This top healthcare company trades at 13 times forward earnings. It has a diverse portfolio of products, yields 3.6% at the ...

Amgen Inc.'s ( NASDAQ:AMGN ) dividend will be increasing from last year's payment of the same period to $2.38 on 7th ...

Amgen Inc (AMGN) stock saw a modest uptick, ending the day at $264.21 which represents a slight increase of $2.15 or 0.82% from the prior close of $262.06. The stock opened at $261.97 and touched a ...

Truist lowered the firm’s price target on Amgen (AMGN) to $298 from $333 and keeps a Hold rating on the shares as part of a broader research ...

Here's why Amgen increased its land holdings in New Albany, even though the pharma giant has plenty of room for expansion on ...

Amgen's Imdylltra gets MHRA nod for ES-SCLC after two prior therapies, offering new hope for aggressive cancer with limited ...

Central Pacific Bank Trust Division lessened its position in Amgen Inc. (NASDAQ:AMGN – Free Report) by 82.3% in the 4th ...